Gilead quarterly profit falls as COVID antiviral sales decrease
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Gilead Sciences (NASDAQ: GILD) | Delayed: 170.68 +5.07 (3.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $165.61 | 52 Week High | $108.63 | |||
| Open | $170.25 | 52 Week Low | $71.39 | |||
| Day High | $175.65 | P/E | 94.30 | |||
| Day Low | $169.00 | EPS | $1.81 | |||
| Volume | 11,425,716 | |||||
